Goldstone Financial Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$461K Buy
6,384
+1,598
+33% +$115K 0.06% 160
2025
Q1
$547K Buy
+4,786
New +$547K 0.08% 126